Page last updated: 2024-09-03

3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone and Alloxan Diabetes

3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, S; Cohen, DM; Komers, R; Lindsley, JN; Oyama, TT; Tian, W1

Other Studies

1 other study(ies) available for 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone and Alloxan Diabetes

ArticleYear
Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes.
    The Journal of laboratory and clinical medicine, 2002, Volume: 140, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Drug Interactions; Enalapril; Furans; Isoenzymes; Kidney; Male; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2002